Sickle Cell Anemia Testing And Screening Market
SHARE
PUBLISHED: 2020 ID: SMRC19966
SHARE

Sickle Cell Anemia Testing and Screening - Global Market Outlook (2019-2027)

4.7 (67 reviews)
4.7 (67 reviews)
Published: 2020 ID: SMRC19966

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Sickle Cell Anemia Testing and Screening Market is accounted for $223.04 million in 2019 and is expected to reach $397.79 million by 2027 growing at a CAGR of 7.5% during the forecast period. Some of the key factors propelling the market growth include increase the uptake of screening products, increasing implementation of strategies to minimize the sickle cell disease burden, rising prevalence of sickle cell disease across the globe. However, infrastructural challenges associated with screening and diagnosis of sickle cell disease is restricting the market growth.

Sickle cell hemoglobin variants are inclusive of HbS, HbA, and HbC. Different tests have been developed to perform a clear distinction between all the three above-mentioned hemoglobin variants. Development of a deep learning framework designed to perform automated screening of sickle cell anemia in blood smear sample of patients via a smartphone microscope is set to open up new avenues for the market in the near future.

By age group, the adult screening segment is expected to grow at the significant rate throughout the forecast period. SCD treatment and management differ at distinct levels based on the patient’s stage. This is attributed to the observed differences in the SCD associated pain, comorbidities, psychosocial impact, and healthcare expenditure with respect to the age group of sickle cell anemia patients. Additionally, increasing number of research activities are aimed at analyzing the impact of age-specific healthcare strategies on improving the management of sickle cell disease population. Employment of targeted screening with respect to age group of sickle cell patients has also extended life span of these patients into adulthood.

On the basis of geography, Asia Pacific region is expected to have considerable market growth during the forecast period. Rising acknowledgment and recognition of sickle cell screening targeted towards newborns have been recently witnessed in the Asia Pacific countries, specifically India. Additionally, these developing countries are devising strategies to address challenges associated with newborn screening programs across high-income countries, which is inclusive of streamlining follow-up screening or diagnosis. This is set to offer a significant momentum to the Asia Pacific market in the near future.

Some of the key players in sickle cell anemia testing and screening market include Request A Test, Ltd., Halcyon Biomedical Incorporated, Silver Lake Research Corporation, Streck, Inc., Daktari Diagnostics, Biomedomics Inc., Laboratory Corporation of America Holdings, PerkinElmer Inc., Quest Diagnostics, Hemotype, Hemex Health, and Bio-Rad Laboratories, Inc.

Age Groups Covered:
• Adult Screening (25 to 60 Years)
• Newborn Screening (12 Months and Below)
• Other Age Groups (1 to 25 & Above 60 Years)

Technologies Covered:
• Point-of-Care Tests
• Hemoglobin Electrophoresis
• High-performance Liquid Chromatography (HPLC)

Sector Types Covered:
• Corporate Labs
• Government Labs
• Public-Private-Partnerships (PPP)
• Private Labs

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary         
          
2 Preface       
  
 2.1 Abstract        
 2.2 Stake Holders        
 2.3 Research Scope        
 2.4 Research Methodology        
  2.4.1 Data Mining       
  2.4.2 Data Analysis       
  2.4.3 Data Validation       
  2.4.4 Research Approach       
 2.5 Research Sources        
  2.5.1 Primary Research Sources       
  2.5.2 Secondary Research Sources       
  2.5.3 Assumptions       
          
3 Market Trend Analysis         
 3.1 Introduction        
 3.2 Drivers        
 3.3 Restraints        
 3.4 Opportunities        
 3.5 Threats        
 3.6 Technology Analysis        
 3.7 Emerging Markets        
 3.8 Impact of Covid-19        
          
4 Porters Five Force Analysis         
 4.1 Bargaining power of suppliers        
 4.2 Bargaining power of buyers        
 4.3 Threat of substitutes        
 4.4 Threat of new entrants        
 4.5 Competitive rivalry        
          
5 Global Sickle Cell Anemia Testing and Screening Market, By Age Group         
 5.1 Introduction        
 5.2 Adult Screening (25 to 60 Years)        
 5.3 Newborn Screening (12 Months and Below)        
 5.4 Other Age Groups (1 to 25 & Above 60 Years)        
          
6 Global Sickle Cell Anemia Testing and Screening Market, By Technology         
 6.1 Introduction        
 6.2 Point-of-Care Tests        
  6.2.1 Paper-Based Rapid Diagnostics       
  6.2.2 Lateral Flow Immunoassay       
 6.3 Hemoglobin Electrophoresis         
  6.3.1 Isoelectric Focusing       
 6.4 High-performance Liquid Chromatography (HPLC)        
          
7 Global Sickle Cell Anemia Testing and Screening Market, By Sector Type         
 7.1 Introduction        
 7.2 Corporate Labs        
 7.3 Government Labs        
 7.4 Public-Private-Partnerships (PPP)        
 7.5 Private Labs        
          
8 Global Sickle Cell Anemia Testing and Screening Market, By Geography         
 8.1 Introduction        
 8.2 North America        
  8.2.1 US       
  8.2.2 Canada       
  8.2.3 Mexico       
 8.3 Europe        
  8.3.1 Germany       
  8.3.2 UK       
  8.3.3 Italy       
  8.3.4 France       
  8.3.5 Spain       
  8.3.6 Rest of Europe       
 8.4 Asia Pacific        
  8.4.1 Japan       
  8.4.2 China       
  8.4.3 India       
  8.4.4 Australia       
  8.4.5 New Zealand       
  8.4.6 South Korea       
  8.4.7 Rest of Asia Pacific       
 8.5 South America        
  8.5.1 Argentina       
  8.5.2 Brazil       
  8.5.3 Chile       
  8.5.4 Rest of South America       
 8.6 Middle East & Africa        
  8.6.1 Saudi Arabia       
  8.6.2 UAE       
  8.6.3 Qatar       
  8.6.4 South Africa       
  8.6.5 Rest of Middle East & Africa       
          
9 Key Developments         
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures        
 9.2 Acquisitions & Mergers        
 9.3 New Product Launch        
 9.4 Expansions        
 9.5 Other Key Strategies        
          
10 Company Profiling         
 10.1 Request A Test, Ltd.        
 10.2 Halcyon Biomedical Incorporated        
 10.3 Silver Lake Research Corporation        
 10.4 Streck, Inc.        
 10.5 Daktari Diagnostics        
 10.6 Biomedomics Inc.        
 10.7 Laboratory Corporation of America Holdings        
 10.8 PerkinElmer Inc.        
 10.9 Quest Diagnostics        
 10.10 Hemotype        
 10.11 Hemex Health        
 10.12 Bio-Rad Laboratories, Inc.        


List of Tables          
1 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Region (2018-2027) ($MN)         
2 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)         
3 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)         
4 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)         
5 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)         
6 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)         
7 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)         
8 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)         
9 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)         
10 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)         
11 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)         
12 Global Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)         
13 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)         
14 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)         
15 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)          
16 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)         
17 Global Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)         
18 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)         
19 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)         
20 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)         
21 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)         
22 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)         
23 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)          
24 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)         
25 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)          
26 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)         
27 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)         
28 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)         
29 North America Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)         
30 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)         
31 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)         
32 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)         
33 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)         
34 North America Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)         
35 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)         
36 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)         
37 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)         
38 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)         
39 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)         
40 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)         
41 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)         
42 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)         
43 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)         
44 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)         
45 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)         
46 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)         
47 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)         
48 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)         
49 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)         
50 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)         
51 Europe Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)         
52 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)         
53 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)         
54 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)         
55 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)         
56 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)         
57 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)         
58 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)         
59 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)         
60 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)         
61 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)         
62 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)         
63 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)         
64 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)         
65 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)         
66 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)         
67 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)         
68 Asia Pacific Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)         
69 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)         
70 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)          
71 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)         
72 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)         
73 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)         
74 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)         
75 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)         
76 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)         
77 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)         
78 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)         
79 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)         
80 South America Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)         
81 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)         
82 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)         
83 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)         
84 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)         
85 South America Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)         
86 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Country (2018-2027) ($MN)         
87 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Age Group (2018-2027) ($MN)         
88 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Adult Screening (25 to 60 Years) (2018-2027) ($MN)         
89 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Newborn Screening (12 Months and Below) (2018-2027) ($MN)         
90 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Other Age Groups (1 to 25 & Above 60 Years) (2018-2027) ($MN)         
91 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Technology (2018-2027) ($MN)         
92 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Point-of-Care Tests (2018-2027) ($MN)         
93 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Paper-Based Rapid Diagnostics (2018-2027) ($MN)         
94 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Lateral Flow Immunoassay (2018-2027) ($MN)         
95 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Hemoglobin Electrophoresis (2018-2027) ($MN)          
96 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Isoelectric Focusing (2018-2027) ($MN)         
97 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By High-performance Liquid Chromatography (HPLC) (2018-2027) ($MN)         
98 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Sector Type (2018-2027) ($MN)         
99 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Corporate Labs (2018-2027) ($MN)         
100 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Government Labs (2018-2027) ($MN)         
101 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Public-Private-Partnerships (PPP) (2018-2027) ($MN)         
102 Middle East & Africa Sickle Cell Anemia Testing and Screening Market Outlook, By Private Labs (2018-2027) ($MN)         

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials